Arcus Biosciences (RCUS) PT Raised to $77 at Truist Securities
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas raised the price target on Arcus Biosciences (NYSE: RCUS) to $77.00 (from $70.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
